Actual medical management of stone diseases in pediatric population

Review ArticleAçık Erişim

Özet

Although the prevalence of urolithiasis is nearly 2-3% in childhood, the risk of recurrence may range between 6.5-54%. There has been an increase in stone disease in the pediatric age groups. The stone disease in children has multifactorial etiology. After the diagnosis, detailed metabolic evaluation is required. High recurrence rates, therapeutic irregularities and deficiency in diagnosis may lead to co-morbidities such as loss of kidney. After the exact diagnosis, surgical options such as stone extraction and correction of the anatomical anomalies come into question. Besides these, medical and supportive treatments are needed for preventing recurrence, urinary infection and, preserving renal function. Supportive care includes increased fluid intake and dietary modifications. Medical treatment depends on the cause of urinary stone disease. Morbidities of pediatric urolithiasis can be prevented by early diagnosis, detailed metabolic analysis, regular follow-up and medical treatment protocols.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15881Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkin, Yigit
dc.contributor.authorUcar, Murat
dc.contributor.authorYucel, Selcuk
dc.date.accessioned2026-10-18T20:30:44.027110744Z
dc.date.available2026-10-18T20:30:44.027110744Z
dc.date.issued2014
dc.description.abstractAlthough the prevalence of urolithiasis is nearly 2-3% in childhood, the risk of recurrence may range between 6.5-54%. There has been an increase in stone disease in the pediatric age groups. The stone disease in children has multifactorial etiology. After the diagnosis, detailed metabolic evaluation is required. High recurrence rates, therapeutic irregularities and deficiency in diagnosis may lead to co-morbidities such as loss of kidney. After the exact diagnosis, surgical options such as stone extraction and correction of the anatomical anomalies come into question. Besides these, medical and supportive treatments are needed for preventing recurrence, urinary infection and, preserving renal function. Supportive care includes increased fluid intake and dietary modifications. Medical treatment depends on the cause of urinary stone disease. Morbidities of pediatric urolithiasis can be prevented by early diagnosis, detailed metabolic analysis, regular follow-up and medical treatment protocols.
dc.identifier.endpage206
dc.identifier.issn0023-5776
dc.identifier.issue3
dc.identifier.scopus2-s2.0-84907332086
dc.identifier.startpage196
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15881
dc.identifier.volume46
dc.language.isoen
dc.publisherKuwait Medical Association
dc.relation.ispartofKuwait Medical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectChildren
dc.subjectHypercalciuria
dc.subjectHypocitraturia
dc.subjectOxaluria
dc.subjectUrolithiasis
dc.subject2,8 dihydroxyadenine
dc.subjectacetazolamide
dc.subjectallopurinol
dc.subjectamiloride
dc.subjectbisphosphonic acid derivative
dc.subjectcalcium oxalate
dc.subjectcalcium phosphate
dc.subjectcaptopril
dc.subjectchlorothiazide
dc.subjectcitrate potassium
dc.subjectfurosemide
dc.subjecthydrochlorothiazide
dc.subjectorotic acid
dc.subjectpenicillamine
dc.subjectpyridoxine
dc.subjectribosephosphate pyrophosphokinase
dc.subjecttiopronin
dc.subjecttopiramate
dc.subjectzonisamide
dc.subject2 8 dihydroxyadenineuria
dc.subjectabnormal urine composition
dc.subjectautosomal recessive disorder
dc.subjectBartter syndrome
dc.subjectbladder stone
dc.subjectcalcium blood level
dc.titleActual medical management of stone diseases in pediatric population
dc.typeReview Article
dspace.entity.typePublication
rdl.citation.scopus0
rdl.source.indexSCOPUS